New York City’s two overdose prevention centers (OPCs) have recorded 250,000 supervised drug uses since opening in 2021, with no fatalities and 2,100 overdose interventions, according to OnPoint NYC Executive Director Sam Rivera. The facilities, operating in East Harlem and Washington Heights, provide sterile equipment, medical supervision, and wraparound services such as primary care, addiction medication, and therapy.
The centers allow injection and inhalation of hard drugs, including heroin and crack cocaine, under medical supervision. Rivera highlighted that these uses occurred inside the facilities rather than on streets, parks, or public restrooms. The program, authorized by the city but not the federal government, aims to reduce overdose deaths and connect users with healthcare and addiction treatment.
Community reactions remain divided. Critics argue the sites attract drug users and dealers, creating safety concerns for nearby residents. An educator at a local school, speaking anonymously, described the scene as “scary for the kids walking into school in the morning.” Supporters, however, point to the centers’ role in preventing fatal overdoses and reducing public drug use.
The facilities offer additional services, including art therapy, sleep rooms, laundry, massage, acupuncture, and aromatherapy, alongside medical care and addiction medication. OnPoint NYC reports 7,000 registered participants since the program’s launch.
The centers operate under New York City’s legal authority, despite federal laws prohibiting facilities that facilitate drug use. The experiment has drawn national attention as a potential model for other cities grappling with opioid and drug crises. Advocates argue the model could be replicated elsewhere, while opponents continue to challenge its legality and effectiveness.